Product Information
QC CHILD IBUPROFEN 100 MG/5 ML is a generic product labeled by Chain Drug Marketing Association, priced at $0.0301 per ML under NDC 83324001304. Its NADAC has been published 96 times since Dec 4, 2024.
FDA first approved this application on Aug 17, 2018.
Strength
100 mg/5mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324001304
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA210149FDA Approved
8/17/2018
On Market Since
11/10/2023
Pharmacological Classes
Price Statistics
The NADAC for QC CHILD IBUPROFEN 100 MG/5 ML has been published 96 times since Dec 4, 2024, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per ML |
|---|---|
| All-time high | $0.0304 (Jun 10, 2026) |
| All-time low | $0.0286 (Mar 19, 2025) |
| 52-week high | $0.0304 |
| 52-week low | $0.0290 |
| Median price | $0.0295 |
| Average price | $0.0294 |
| Largest weekly change | +2.5% (May 20, 2026) |
| Weeks tracked | 96 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC CHILD IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for QC CHILD IBUPROFEN 100 MG/5 ML, manufactured by Chain Drug Marketing Association, is $0.0301 per ML (NDC 83324001304), effective Sep 30, 2026.
How has the price of QC CHILD IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for QC CHILD IBUPROFEN 100 MG/5 ML has risen 3.0%. It has been tracked across 96 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC CHILD IBUPROFEN 100 MG/5 ML?
Since Dec 4, 2024, the NADAC for QC CHILD IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0286 (Mar 19, 2025) to a high of $0.0304 (Jun 10, 2026), with a median of $0.0295 per ML.
Are there cheaper alternatives to QC CHILD IBUPROFEN 100 MG/5 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC CHILD IBUPROFEN 100 MG/5 ML, is $0.0297 per ML — about 1% below QC CHILD IBUPROFEN 100 MG/5 ML.
Who manufactures QC CHILD IBUPROFEN 100 MG/5 ML?
QC CHILD IBUPROFEN 100 MG/5 ML (NDC 83324001304) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.